Sort by
Refine Your Search
-
transition metal catalysis Quanhan Xi Doctor of Philosophy in Statistics (PhD) Representing latent interventions in generative models Sydney Moore Doctor of Philosophy in Applied Animal Biology (PhD) Improving
-
include a significant research component (ie. coursework-based programs such as MPPGA, MOT, MPH, MPT, and MKIN) Doctor of Pharmacy Other Funding While award recipients will be selected based
-
the program requires additional admission into the major research component stream, this acceptance must be confirmed before you can hold the award. Joint programs with a professional degree (for example, MD
-
into the major research component stream, this acceptance must be confirmed before you can hold the award. Joint programs with a professional degree (for example, MD/PhD, DVM/PhD, JD/MA, JD/PhD, MBA/PhD, MA/MBA
-
significant research component (i.e. coursework only) Doctor of Pharmacy, EDD, and DMA PhD students will not be considered for AGF Bridge funding. All PhD students who would otherwise be eligible (i.e. in
-
are unsure which granting agency they should select, they should consult their research supervisor and/or Graduate Advisor. In cases where clarification is still needed, applicants should send a half-page
-
Instructions posted here for details on each of the above items. Some applicants may be eligible to apply via the main IGF competition or the IGF 5th Year Award competition. Please contact graduate.awards
-
Hendry Doctor of Philosophy in Population and Public Health (PhD) Measuring & Responding to Racism in Public Health: Evaluating Tools, Identifying Indicators, and Assessing Leadership Readiness in British
-
and its potential appeal and benefit to graduate students from various departments and faculties; a list of potential public speakers and public events; and ideas about the public scholarship component
-
supplements during pregnancy: a cluster-randomized non-inferiority trial in Cambodia Samuel Tobias Doctor of Philosophy in Population and Public Health (PhD) The evolving unregulated drug supply and its impact